本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cellectar Biosciences Inc.

0.2516
-0.0394-13.54%
成交量:203.55万
成交额:52.57万
市值:1,159.37万
市盈率:-0.18
高:0.2800
开:0.2800
低:0.2400
收:0.2910
数据加载中...
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/11

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]